Compare Moderna, Inc. (MRNA) vs Sea Limited (SE) Price & Performance

Moderna, Inc.Trade

Sea LimitedTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Sea Limited — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Sea Limited trades at $106.26 (market cap $64.73B). The key difference: Sea Limited is far larger — about 2.7× Moderna, Inc.'s market cap, and Moderna, Inc. is trading nearer its 52-week high, Sea Limited nearer its low. Which is the better fit depends on your goals.

	MRNA	SE
Market Cap	$23.60B	$64.73B
Sector	Health	Media
52-Week High	$81.80	$196.50
52-Week Low	$22.36	$78.16
Enterprise Value	$19.70B	$57.78B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 12 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

Sea Limited stock drops 32% despite stronger fundamentals, seen as market disconnect by analystSeeking Alpha · 16 hours agoBullish Sea Limited posts $7B revenue and $1B EBITDA in Q1 2026, showing strong growth and profitability.Seeking Alpha · 4 days agoBullish View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Sea Limited

Sea Limited offers information technology services. The Company provides online personal computer and mobile digital content, e-commerce, and payment platforms. Sea serves customers worldwide.